Minimal residual disease is common after allogeneic stem cell transplantation in patients with B cell chronic lymphocytic leukemia and may be controlled by graft-versus-host disease

✍ Scribed by Mattsson, J; Uzunel, M; Remberger, M; Ljungman, P; Kimby, E; Ringdén, O; Zetterquist, H

• Book ID: 110054452
• Publisher: Nature Publishing Group
• Year: 2000
• Tongue: English
• Weight: 167 KB
• Volume: 14
• Category: Article
• ISSN: 0887-6924
• DOI: 10.1038/sj.leu.2401669